Novo Nordisk | NVO - Passività Correnti

Prezzo Delle Azioni
37.87
Cambio Giornaliero
0.45 1.20%
Mensile
-2.45%
Annuale
-41.49%
Q2 Previsione
35.64




Passività Correnti Cambiamento Data
ANI Pharmaceuticals USD 278.11M 7.56M 2025-12
Aurora Cannabis CAD 145.94M 21.82M 2025-12
Bausch Health Companies USD 4.18B 613M 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Canopy Growth CAD 98.29M 17.19M 2025-12
Corcept Therapeutics USD 166.08M 6.18M 2025-12
Drreddys Laboratories INR 1.76B 62.5M 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Merck USD 28.63B 2.59B 2025-09
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Novo Nordisk DKK 215.66B 18.7B 2025-12
Novo Nordisk DKK 32.79B 203.33B 2025-06
Pacira USD 120.59M 13.51M 2025-12
Perrigo USD 1.01B 132.4M 2025-12
Phibro Animal Health USD 282.37M 12.23M 2025-12
Prestige Brands USD 139.56M 4.95M 2025-12
Sanofi EUR 28.35B 3.76B 2025-12
Supernus Pharmaceuticals USD 338.17M 7.54M 2025-12
Zoetis USD 2.24B 428M 2025-12